Asthma Research Today is a free monthly online journal that collates and summarizes the latest research about Asthma, including details on symptoms, diagnosis, treatment, causes, medications.

Volume 2 (2005), Issue 8 (August)

1. CXCR3 polymorphisms associated with risk of asthma.
   Biochem Biophys Res Commun, 334(4): 1219-25. [Abstract] [Full-text]
2. Thioredoxin suppresses airway hyperresponsiveness and airway inflammation in asthma.
   Biochem Biophys Res Commun, 334(4): 1141-8. [Abstract] [Full-text]
3. Modification of dendritic cell function as a tool to prevent and treat allergic asthma.
   Vaccine, 23(37): 4577-88. [Abstract] [Full-text]
4. Individual and neighborhood-level factors in predicting asthma.
   Arch Pediatr Adolesc Med, 159(8): 759-63. [Abstract] [Full-text]
5. Small airways function and molecular markers in exhaled air in mild asthma.
   Thorax, 60(8): 639-44. [Abstract] [Full-text]
6. Asthma and incident cardiovascular disease: the Atherosclerosis Risk in Communities Study.
   Thorax, 60(8): 633-8. [Abstract] [Full-text]
7. Impact of changes in the IOC-MC asthma criteria: a British perspective.
   Thorax, 60(8): 629-32. [Abstract] [Full-text]
8. A novel tissue inhibitor of metalloproteinase-1 (TIMP-1) polymorphism associated with asthma in Australian women.
   Thorax, 60(8): 623-8. [Abstract] [Full-text]
9. An application of model-fitting procedures for marginal structural models.
   Am J Epidemiol, 162(4): 382-8. [Abstract] [Full-text]
10. Asthma severity and exposure to occupational asthmogens.
    Am J Respir Crit Care Med, 172(4): 440-5. [Abstract] [Full-text]
11. Repeated exposure to ozone increases alveolar macrophage recruitment into asthmatic airways.
    Am J Respir Crit Care Med, 172(4): 427-32. [Abstract] [Full-text]
12. Genomewide screen for pulmonary function in 200 families ascertained for asthma.
    Am J Respir Crit Care Med, 172(4): 446-52. [Abstract] [Full-text]
13. Exhaled nitric oxide: a predictor of steroid response.
    Am J Respir Crit Care Med, 172(4): 453-9. [Abstract] [Full-text]
14. Interleukin-10 gene expression in acute virus-induced asthma.
    Am J Respir Crit Care Med, 172(4): 433-9. [Abstract] [Full-text]
15. Differential effects of (S)- and (R)-enantiomers of albuterol in a mouse asthma model.
    J Allergy Clin Immunol, 116(2): 332-40. [Abstract] [Full-text]
16. Dissecting asthma using focused transgenic modeling and functional genomics.
    J Allergy Clin Immunol, 116(2): 305-11. [Abstract] [Full-text]
17. Duration of postviral airway hyperresponsiveness in children with asthma: effect of atopy.
    J Allergy Clin Immunol, 116(2): 299-304. [Abstract] [Full-text]
18. Roflumilast, an oral, once-daily phosphodiesterase 4 inhibitor, attenuates allergen-induced asthmatic reactions.
    J Allergy Clin Immunol, 116(2): 292-8. [Abstract] [Full-text]
19. Effect of low-dose ciclesonide on allergen-induced responses in subjects with mild allergic asthma.
    J Allergy Clin Immunol, 116(2): 285-91. [Abstract] [Full-text]
20. Perspectives on the past decade of asthma genetics.
    J Allergy Clin Immunol, 116(2): 274-8. [Abstract] [Full-text]
21. The role of rhinovirus in asthma exacerbations.
    J Allergy Clin Immunol, 116(2): 267-73. [Abstract] [Full-text]
22. Impact of disease severity on quality of life in adults with asthma.
    Wien Klin Wochenschr, 117(13): 462-7. [Abstract] [Full-text]
23. A novel (TG)n(GA)m repeat polymorphism 254 bp downstream of the mast cell chymase (CMA1) gene is associated with atopic asthma and total serum IgE levels.
    J Hum Genet, 50(6): 276-82. [Abstract] [Full-text]
24. Relation of beta2-adrenoceptor polymorphisms at codons 16 and 27 to persistence of asthma symptoms after the onset of puberty.
    Chest, 128(2): 609-17. [Abstract] [Full-text]
25. Short-acting beta-agonist prescription fills as a marker for asthma morbidity.
    Chest, 128(2): 602-8. [Abstract] [Full-text]
26. Ozone therapy effects on biomarkers and lung function in asthma.
    Arch Med Res, 36(5): 549-54. [Abstract] [Full-text]
27. Leukocyte oxidant and antioxidant status in asthmatic patients.
    Arch Med Res, 36(5): 502-6. [Abstract] [Full-text]
28. Novel allele of the endothelial nitric oxide synthase gene polymorphism in Caucasian asthmatics.
    Biochem Biophys Res Commun, 335(2): 545-9. [Abstract] [Full-text]
29. Airway proteoglycans are differentially altered in fatal asthma.
    J Pathol, 207(1): 102-10. [Abstract] [Full-text]
30. Allergen challenge alters intracellular cytokine expression.
    Scand J Immunol, 62(2): 161-7. [Abstract] [Full-text]
31. Acute inhibition of inducible nitric oxide synthase but not its absence suppresses asthma-like responses.
    Eur J Pharmacol, 518(2): 212-20. [Abstract] [Full-text]
32. Local nitric oxide levels reflect the degree of allergic airway inflammation after segmental allergen challenge in asthmatics.
    Nitric Oxide, 13(2): 125-33. [Abstract] [Full-text]
33. BCG immunization at birth and atopic diseases in a homogeneous population of Spanish schoolchildren.
    Int Arch Allergy Immunol, 137(4): 303-9. [Abstract] [Full-text]
34. Genetic and environmental factors in the immunopathogenesis of atopy: interaction of Helicobacter pylori infection and IL4 genetics.
    Int Arch Allergy Immunol, 137(4): 282-8. [Abstract] [Full-text]
35. Potential role of stem cell factor in the asthma control by glucocorticoids.
    Chem Immunol Allergy, 87: 154-62. [Abstract] [Full-text]
36. Mast cells in allergic airway disease and chronic rhinosinusitis.
    Chem Immunol Allergy, 87: 111-29. [Abstract] [Full-text]
37. Asthma, chronic bronchitis, and exposure to irritant agents in occupational domestic cleaning: a nested case-control study.
    Occup Environ Med, 62(9): 598-606. [Abstract] [Full-text]
38. Viruses as the causative agent related to 'dampness' and the missing link between allergen exposure and onset of allergic disease.
    Indoor Air, 15(5): 363-6. [Abstract] [Full-text]
39. Best evidence topic report. Nebulised furosemide in acute adult asthma.
    Emerg Med J, 22(9): 654-5. [Abstract] [Full-text]
40. Pressurised metered dose inhalers with spacers versus nebulisers for beta-agonist delivery in acute asthma in children in the emergency department.
    Emerg Med J, 22(9): 641-2. [Abstract] [Full-text]
41. Acid suppression does not change respiratory symptoms in children with asthma and gastro-oesophageal reflux disease.
    Arch Dis Child, 90(9): 956-60. [Abstract] [Full-text]
42. Immunological methods for quantifying free and total serum IgE levels in allergy patients receiving omalizumab (Xolair) therapy.
    J Immunol Methods, 303(1): 81-91. [Abstract] [Full-text]
43. How accurate is the diagnosis of exercise induced asthma among Vancouver schoolchildren?
    Arch Dis Child, 90(9): 898-902. [Abstract] [Full-text]
44. Training general practitioners in behavior change counseling to improve asthma medication adherence.
    Patient Educ Couns, 58(3): 279-87. [Abstract] [Full-text]
45. The prevalence of ibuprofen-sensitive asthma in children: a randomized controlled bronchoprovocation challenge study.
    J Pediatr, 147(2): 233-8. [Abstract] [Full-text]
46. Comparative efficacy and safety of low-dose fluticasone propionate and montelukast in children with persistent asthma.
    J Pediatr, 147(2): 213-20. [Abstract] [Full-text]
47. Adaptation to past malarial endemia and susceptibility to common diseases in modern populations: a study of adenosine deaminase and MN blood group genetic polymorphisms.
    Am J Phys Anthropol, 128(1): 194-8. [Abstract] [Full-text]
48. Intercellular adhesion molecule-1 and childhood asthma.
    Hum Genet, 117(5): 476-84. [Abstract] [Full-text]

© 2004-2008 Asthma Research Today. All Rights Reserved.